id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-253056-765rs3e7	Dionne, Audrey	Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection	2018-10-17		.txt	text/plain	3725	208	45	title: Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection Children with persistent or recurrent fever 36 hours after the end of intravenous immunoglobulin (IVIG) are considered to be resistant to treatment and are at increased risk for coronary complications. RESULTS: Children with concomitant infection were more likely to have fever 48 hours after initial IVIG treatment (36% vs 20%, p = 0.05) and to be treated with a second dose (33% vs 18%, p = 0.04). Children with concurrent infection had higher rates of IVIG resistance (19 (33%) versus 17 (18%) patients, p = 0.04), and higher temperature at 48 hours (Fig 1) . In this retrospective series, the presence of a concomitant infection was associated with a higher rate of resistance to IVIG treatment. In this study, patients with concomitant infection had a higher rate of resistance to IVIG treatment.	./cache/cord-253056-765rs3e7.txt	./txt/cord-253056-765rs3e7.txt